Tato stránka byla automaticky přeložena a přesnost překladu není zaručena. Podívejte se prosím na anglická verze pro zdrojový text.

An Observational Study Measuring in a Non-invasive Approach the Nociception Level Index and Its Association With Pain and Anxieiy Perception Evaluated by Questionnaires, in Awake Women During Elective Cesarean Delivery Under Spinal Anesthesiaanxiety

22. července 2026 aktualizováno: Michael Grach

A Prospective Observational Study Evaluating the Nociception Level Index and Its Association With Pain Perception, Anxiety, Uterine Activity, and Autonomic Responses During Elective Cesarean Delivery Under Spinal Anesthesia

The Nociception Level (NOL) Index is a multiparametric, non-invasive monitor that objectively assesses nociception by integrating several autonomic physiological signals. Although the NOL Index has been extensively validated during general anesthesia, its performance in awake patients undergoing regional anesthesia remains poorly understood. During cesarean delivery (CD) under spinal anesthesia, autonomic responses may be influenced not only by nociceptive stimulation but also by anxiety, uterine contractions, hemodynamic changes, uterotonic medications, and other non-nociceptive factors. Understanding the relative contribution of these factors is essential before the NOL Index can be reliably applied in awake surgical patients.

This prospective observational study aims to characterize the behavior of the NOL Index throughout elective CD performed under spinal anesthesia and to evaluate its relationship with subjective pain intensity, anxiety, uterine activity, perioperative autonomic responses, and routine physiological variables.

Approximately 100 women undergoing elective CD under spinal anesthesia will be enrolled at Carmel Medical Center. Continuous NOL monitoring using the PMD-200 system will be performed from before spinal anesthesia until the early postoperative period. Subjective pain (Visual Analog Scale), anxiety (Visual Analog Scale for Anxiety), uterine activity, hemodynamic variables, perioperative medications, and predefined surgical events will be prospectively recorded and synchronized with continuous NOL measurements. Potential confounding factors, including vasopressor administration, uterotonic drugs, nausea, shivering, patient movement, and supplemental analgesia, will also be documented.

This study will provide one of the first comprehensive evaluations of continuous NOL monitoring during CD under spinal anesthesia. The results are expected to improve the understanding of objective nociception monitoring in awake patients, clarify the influence of non-nociceptive autonomic activation on the NOL Index, and help define the clinical role and limitations of NOL monitoring during regional anesthesia, and may contribute to the future development of objective pain assessment strategies in obstetric anesthesia and other clinical settings involving awake patients.

Přehled studie

Postavení

Zatím nenabíráme

Podmínky

Detailní popis

Elective cesarean delivery performed under spinal anesthesia provides a unique and highly reproducible clinical model for investigating objective nociception monitoring in awake patients. Unlike patients undergoing general anesthesia, women receiving spinal anesthesia remain conscious throughout surgery, allowing simultaneous assessment of subjective pain perception, anxiety, autonomic physiological responses, and objective nociception monitoring under standardized surgical conditions.

The Nociception Level (NOL) Index is a multiparametric physiological monitoring system that integrates several autonomic variables, including heart rate variability, skin conductance, photoplethysmographic waveform characteristics, and additional physiological parameters using a proprietary machine-learning algorithm. The NOL Index has been extensively validated during general anesthesia and has demonstrated good correlation with surgical stimulation and analgesic adequacy. However, its performance during regional anesthesia, particularly in awake obstetric patients, remains insufficiently characterized.

During cesarean delivery under spinal anesthesia, multiple physiological and psychological factors may influence autonomic nervous system activity independently of nociceptive stimulation. These include preoperative and intraoperative anxiety, emotional stress, patient communication, uterine manipulation, uterine contractions following administration of uterotonic agents, hemodynamic changes associated with neuraxial anesthesia, vasopressor administration, nausea, shivering, and patient movement. Consequently, interpretation of the NOL Index in this setting requires further clinical investigation.

This prospective, single-center observational study will enroll approximately 100 women undergoing elective cesarean delivery under spinal anesthesia at Carmel Medical Center, Haifa, Israel. Standard perioperative management will not be modified for study purposes. Continuous NOL monitoring will begin before initiation of spinal anesthesia and continue throughout surgery and the early postoperative recovery period.

Simultaneously, subjective pain intensity will be assessed using the Visual Analog Scale (VAS), anxiety will be evaluated using the Visual Analog Scale for Anxiety (VAS-A), and routine physiological variables including heart rate, blood pressure, mean arterial pressure, and oxygen saturation will be recorded. Surgical milestones, administration of intrathecal medications, uterotonic agents, vasopressors, rescue analgesia, and other clinically relevant medications will be prospectively documented and synchronized with continuous NOL recordings.

The primary objective of the study is to characterize the intraoperative behavior of the NOL Index and determine the percentage of monitoring time during which NOL values remain outside the predefined target range of 10-25. Secondary objectives include evaluation of the relationships between the NOL Index and subjective pain intensity, anxiety, uterine activity, surgical phases, rescue analgesia requirements, and perioperative autonomic responses.

Potential confounding factors known to influence autonomic nervous system activity-including maternal anxiety, hypotension, vasopressor administration, uterotonic medications, nausea, shivering, supplemental analgesia, sedation, and patient movement-will be prospectively documented and considered during statistical analyses. Continuous NOL data will be automatically recorded according to the device sampling frequency and exported for offline analysis following predefined quality-control procedures.

The findings of this study are expected to improve understanding of objective nociception monitoring in awake patients undergoing regional anesthesia and to define the clinical utility and limitations of the NOL Index in obstetric anesthesia. The results may contribute to optimizing intraoperative pain assessment, improving interpretation of physiological monitoring during regional anesthesia, and guiding future research on objective nociception monitoring in conscious surgical patients.

Typ studie

Pozorovací

Zápis (Odhadovaný)

100

Kontakty a umístění

Tato část poskytuje kontaktní údaje pro ty, kteří studii provádějí, a informace o tom, kde se tato studie provádí.

Studijní kontakt

  • Jméno: Michael Grach, MD Dr.
  • Telefonní číslo: +972506265753
  • E-mail: Grachm@gmail.com

Studijní záloha kontaktů

Studijní místa

      • Haifa, Izrael, 3436212
        • Carmel Medical Center
        • Kontakt:
          • Michael Grach, MD Dr.
          • Telefonní číslo: 972-506265753
          • E-mail: Grachm@gmail.com
        • Kontakt:

Kritéria účasti

Výzkumníci hledají lidi, kteří odpovídají určitému popisu, kterému se říká kritéria způsobilosti. Některé příklady těchto kritérií jsou celkový zdravotní stav osoby nebo předchozí léčba.

Kritéria způsobilosti

Věk způsobilý ke studiu

  • Dospělý

Přijímá zdravé dobrovolníky

Ne

Metoda odběru vzorků

Vzorek nepravděpodobnosti

Studijní populace

Women ≥18 years, ASA I-III, scheduled to elective cesarean delivery under spinal anesthesia

Popis

Inclusion Criteria:

  • Women ≥18 years
  • Scheduled to elective cesarean delivery under spinal anesthesia
  • ASA I-III
  • Able to provide informed consent

Exclusion Criteria:

  • Women Age <18 years
  • BMI >35 kg/m²
  • Major psychiatric illness
  • Chronic psychotropic/anxiolytic therapy
  • Substance abuse
  • Inability to communicate
  • Contraindication to spinal anesthesia
  • Any pre condition interfering with study participation

Studijní plán

Tato část poskytuje podrobnosti o studijním plánu, včetně toho, jak je studie navržena a co studie měří.

Jak je studie koncipována?

Detaily designu

Co je měření studie?

Primární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Percentage of intraoperative monitoring time during which the Nociception Level Index remains outside the predefined target range (10-25) during elective cesarean delivery under spinal anesthesia
Časové okno: Intraoperative period up to 3 hours
Nociception Level Index a physiological parameter measurment obtained, in a non invasive way, by a probe attached to the index finger, recording every 5 seconds. (range 0-100) 0 no pain 100 worst pain
Intraoperative period up to 3 hours

Sekundární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Duration of Nociception Level Index (>25)
Časové okno: Intraoperative period and approximately 1 hour postoperatively, up to 5 hours
Nociception Level Index a physiological parameter measurment obtained, in a non invasive way, by a probe attached to the index finger, recording every 5 seconds. (range 0-100) 0 no pain 100 worst pain. Recording duration when values exceeding over 25
Intraoperative period and approximately 1 hour postoperatively, up to 5 hours
Correlation between Nociception Level Index and Visual Analog Scale
Časové okno: : Intraoperative period and approximately 1 hour postoperatively up to 5 hours
Correlation between Nociception Level Index a physiological parameter measurment obtained, in a non invasive way, by a probe attached to the index finger, recording every 5 seconds. (range 0-100) 0 no pain 100 worst pain and Visual analog scale scores by questionnaires, range 1-10 at 3 time points: preoperative, 0- no pain 10 worst pain
: Intraoperative period and approximately 1 hour postoperatively up to 5 hours
Correlation between Nociception Level Index and Visual Analogue Scale- anxiety
Časové okno: Intraoperative period and approximately 1 hour postoperatively up to 5 hours
Correlation between Nociception Level Index a physiological parameter measurment obtained, in a non invasive way, by a probe attached to the index finger, recording every 5 seconds. (range 0-100) 0 no pain 100 worst pain and Visual analog scale- Anxiety scores by questionnaires, range 1-10 at 3 time points: preoperative, 0- no pain 10 worst pain
Intraoperative period and approximately 1 hour postoperatively up to 5 hours
Surgical phase analysis
Časové okno: Intraoperative period and approximately 1 hour postoperatively
Intraoperative period and approximately 1 hour postoperatively
Association of Nociception Level Index with uterine activity
Časové okno: Intraoperative period and approximately 1 hour postoperatively up to 5 hours
Nociception Level Index a physiological parameter measurment obtained, in a non invasive way, by a probe attached to the index finger, recording every 5 seconds. (range 0-100) 0 no pain 100 worst pain. Uterine activity as assessed by the surgeon to determine unterine contrations
Intraoperative period and approximately 1 hour postoperatively up to 5 hours
Rescue analgesia requirements
Časové okno: Intraoperative period and approximately 1 hour postoperatively up to 5 hours
Recording analgesia requirements dosages
Intraoperative period and approximately 1 hour postoperatively up to 5 hours

Spolupracovníci a vyšetřovatelé

Zde najdete lidi a organizace zapojené do této studie.

Sponzor

Publikace a užitečné odkazy

Osoba odpovědná za zadávání informací o studiu tyto publikace poskytuje dobrovolně. Mohou se týkat čehokoli, co souvisí se studiem.

Obecné publikace

Termíny studijních záznamů

Tato data sledují průběh záznamů studie a předkládání souhrnných výsledků na ClinicalTrials.gov. Záznamy ze studií a hlášené výsledky jsou před zveřejněním na veřejné webové stránce přezkoumány Národní lékařskou knihovnou (NLM), aby se ujistily, že splňují specifické standardy kontroly kvality.

Hlavní termíny studia

Začátek studia (Odhadovaný)

15. srpna 2026

Primární dokončení (Odhadovaný)

30. července 2027

Dokončení studie (Odhadovaný)

30. července 2027

Termíny zápisu do studia

První předloženo

11. července 2026

První předloženo, které splnilo kritéria kontroly kvality

22. července 2026

První zveřejněno (Aktuální)

24. července 2026

Aktualizace studijních záznamů

Poslední zveřejněná aktualizace (Aktuální)

24. července 2026

Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality

22. července 2026

Naposledy ověřeno

1. července 2026

Více informací

Termíny související s touto studií

Další relevantní podmínky MeSH

Další identifikační čísla studie

  • 0005-26-CMC

Plán pro data jednotlivých účastníků (IPD)

Plánujete sdílet data jednotlivých účastníků (IPD)?

NEROZHODNÝ

Popis plánu IPD

IPD sharing will be decided depending on requirement for publication or demand by researcher

Informace o lécích a zařízeních, studijní dokumenty

Studuje lékový produkt regulovaný americkým FDA

Ne

Studuje produkt zařízení regulovaný americkým úřadem FDA

Ne

Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .